1-METHYL-4-OXO-9-(p-NITROPHENACYL)-1H,2,3,4,9-TETRAHYDROPYRROLO(2,3-B)QUINOLINE (60315-52-8)

Identification
Name:	1-METHYL-4-OXO-9-(p-NITROPHENACYL)-1H,2,3,4,9-TETRAHYDROPYRROLO(2,3-B)QUINOLINE
Synonyms:	2,3,4,9-Tetrahydro-1-methyl-9-[2-(4-nitrophenyl)-2-oxoethyl]-1H-pyrrolo[2,3-b]quinolin-4-one
CAS:	60315-52-8
Molecular Formula:	C20H17N3O4
Molecular Weight:	0
InChI:	InChI=1/C20H17N3O4/c1-21-11-10-16-19(25)15-4-2-3-5-17(15)22(20(16)21)12-18(24)13-6-8-14(9-7-13)23(26)27/h2-9H,10-12H2,1H3
Molecular Structure:
Properties
Flash Point:	291.8°C
Boiling Point:	558.8°C at 760 mmHg
Density:	1.43g/cm³
Refractive index:	1.697
Flash Point:	291.8°C
Safety Data

Other Product

Acetic acid 2,6-dimethoxy-4-(9-oxo-1,2,3,9-tetrahydropyrrolo[2,1-b]quinazolin-3-ylidenemethyl)phenyl ester
2-Chloro-4-nitrophenacyl bromide
diethyl 2-methyl-9-oxo-3,3a,4,9-tetrahydropyrrolo[2,1-b]quinazoline-1,1(2H)-dicarboxylate
N-[9-Amino-4-oxo-1-phenyl-3,4,6,7-tetrahydropyrrolo[3,2,1-jk][1,4]benzodiazepin- 3(R)-yl]pyridine-3-carboxamide
1-cyclopropyl-6,8-difluoro-7-(5-methyl-3,4,5,6-tetrahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid - 2-hydroxypropanoic acid (1:1)
9-fluoro-3-hydroxy-5-methyl-1-oxo-N-(pyridin-4-ylmethyl)-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-2-carboxamide
triethyl 1-methyl-4-oxo-4,5,6,7-tetrahydropyrrolo[2,3-b]azepine-3,5,8(1H)-tricarboxylate
N-cyclohexyl-2-(4-methoxybenzyl)-4,5,6-trimethyl-3-oxo-1,2,3,5-tetrahydropyrrolo[3,4-c]pyrrole-1-carboxamide
Indolizino[1,2-b]quinoline-8-carboxamide,9,11-dihydro-7-methyl-9-oxo-3-[2-(1-piperidinyl)ethoxy]-,monohydrochloride
5H-[1]Benzopyrano[4,3-b]pyridine-3-carbonitrile,9-bromo-2-methyl-5-oxo-4-phenyl-
Pyrrolo[2,1-b]quinazoline-2-carbonitrile,1-amino-1,2,3,9-tetrahydro-3-[(4-methylphenyl)methyl]-9-oxo-
Pyrrolo[2,1-b]quinazoline-2-carbonitrile,1-amino-3-[(4-chlorophenyl)methyl]-1,2,3,9-tetrahydro-9-oxo-
2,3,4,10-Tetrahydro-1-methyl-10-(p-nitrophenacyl)benzo[b][1,8]naphthyridin-5-one
1H-5,6,8b-Triazaacenaphthylene-3-carboxylicacid, 2,2a,3,4,5,7,8,8a-octahydro-4-methyl-7-nonyl-,9-[(3R)-1-amino-4-[[4-[(aminoiminomethyl)amino]butoxy]carbonyl]-3,5,6,7-tetrahydropyrrolo[1,2-c]pyrimidin-3-yl]nonylester, (2aS,3S,4R,7R,8aS)-
1H-5,6,8b-Triazaacenaphthylene-3-carboxylicacid, 7-heptyl-2,2a,5,7,8,8a-hexahydro-4-methyl-,9-[(3R)-1-amino-4-[[4-[(aminoiminomethyl)amino]butoxy]carbonyl]-3,5,6,7-tetrahydropyrrolo[1,2-c]pyrimidin-3-yl]nonylester, (2aR,7R,8aS)-
9-methoxy-4-[(3-methylbut-2-en-1-yl)oxy][1,3]dioxolo[4,5-g]furo[2,3-b]quinoline
1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,4-ethyl-4-hydroxy-9-methyl-
7-methyl-9-[4-(4-methylphenyl)piperazin-1-yl]-2,3-dihydro-1H-cyclopenta[b]quinoline
5-methyl-9-[4-(4-methylphenyl)piperazin-1-yl]-2,3-dihydro-1H-cyclopenta[b]quinoline
2H-Pyrazino[2,1-b]quinazoline-3,6(1H,4H)-dione,1-methoxy-1-methyl-4-[[(2S,9S,9aS)-2,3,9,9a-tetrahydro-9-hydroxy-2-methyl-3-oxo-1H-imidazo[1,2-a]indol-9-yl]methyl]-,(1R,4R)-